Editorial|Volume 10, Issue 11|pp 3042—3043

IDOL in metabolic, neurodegenerative and cardiovascular disease

Nienke M. van Loon¹, Patrick C.N. Rensen², Noam Zelcer¹

¹Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, 1105AZ Amsterdam, The Netherlands
²Department of Medicine, Division of Endocrinology and Einthoven Laboratory for Experimental Vascular and Regenerative Medicine, Leiden University Medical Center, 2333ZA Leiden, the Netherlands

Received: September 27, 2018Accepted: October 13, 2018Published: October 14, 2018

Copyright: © 2018 van Loon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.